N-acetylcysteine is a naturally occurring molecule that replenishes antioxidants and shows improved brain metabolism and self-reported improvements in cognitive function in patients with multiple sclerosis, according to a study published in the journal, Frontiers in Neurology.
Read More

Cardiologists at The Ohio State University Wexner Medical Center are the first in the United States to test a new type of ablation technology for patients suffering from atrial fibrillation, a common type of irregular heartbeat.
Read More

With a new CRISPR gene-editing methodology, scientists from the University of Illinois at Urbana-Champaign inactivated one of the genes responsible for an inherited form of amyotrophic lateral sclerosis – a debilitating and fatal neurological disease for which there is no cure.
Read More

Rates of diagnosed attention deficit-hyperactivity disorder in veterans receiving care in the VA health system more than doubled during the past decade, reports a study in the March issue of Medical Care.
Read More

Melbourne researchers have uncovered important differences between the male and female immune system which may explain why men are more susceptible to obesity and metabolism-related associated diseases, such as heart disease, stroke and diabetes.
Read More

According to a February 13 report from the World Health Organization, the Wuhan coronavirus has stricken more than 46,000 people and has caused over 1,300 deaths since the first cases in Wuhan, China, in December 2019.
Read More

Public health agencies worldwide have identified antibiotic resistance of disease-causing bacteria as one of humanity’s most critical challenges. However, scientists haven’t discovered a new class of antibiotics in more than 30 years.
Read More

A team of scientists at the Hong Kong University of Science and Technology (HKUST) has recently made an important discovery in identifying a set of potential vaccine targets for the SARS-CoV-2 coronavirus, providing crucial leads for guiding experimental efforts towards the vaccine development against the novel pneumonia (COVID-19) caused by the virus.
Read More

An investigational drug that binds bile acids in the stomach can reduce the severity of heartburn symptoms in patients with treatment-resistant gastroesophageal reflux disease (GERD) when combined with a proton pump inhibitor (PPI), a new study suggests.
Read More

The latest outbreak was from November to December 2019 in Iowa, where 22 people were infected with E. coli. Twenty of them were interviewed, and each said they ate at one or more of 15 Jimmy John’s locations

Read More